Strata Skin Sciences to be delisted from Nasdaq on Feb 19 after failing equity requirement

STRATA Skin Sciences, Inc.

Company failed to meet Nasdaq's minimum $2.5M stockholders' equity; funding efforts unsuccessful.
Nasdaq suspension of trading effective Feb 19, 2026; company will not appeal.
Plans to file Form 25 to delist and Form 15 to terminate SEC registration and 'go dark'.
Expects cost savings from reduced reporting obligations, enabling focus on operations and cash burn.
Stockholders face increased illiquidity; may sell shares before suspension.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.